A genetic screen identifies TCF3/E2A and TRIAP1 as pathway-specific regulators of the cellular response to p53

Zdenek Andrysik1, Jihye Kim, Aik Choon Tan

  • 1Howard Hughes Medical Institute & Department of Molecular, Cellular and Developmental Biology, University of Colorado at Boulder, Boulder, CO 80309, USA.

Cell Reports
|May 21, 2013
PubMed

Insights

Researchers identified key regulators of the p53 pathway, uncovering TCF3/E2A and TRIAP1. Their findings offer strategies to direct p53-activated cells towards specific outcomes like cell-cycle arrest or apoptosis.

Area of Science:

  • Molecular Biology
  • Cellular Stress Response
  • Cancer Biology

Background:

  • The p53 transcription factor orchestrates critical cellular responses to stress, including cell-cycle arrest and apoptosis.
  • The precise molecular mechanisms dictating the specific outcome of p53 activation remain incompletely understood.
  • Understanding these mechanisms is crucial for developing targeted cancer therapies.

Purpose of the Study:

  • To identify novel pathway-specific coregulators of p53 target genes.
  • To differentiate regulators controlling cell-cycle arrest (p21) versus apoptosis (PUMA).
  • To elucidate strategies for manipulating p53-dependent cellular fate.

Main Methods:

  • Genome-wide genetic screen in human cells to identify p53 pathway coregulators.
  • Analysis of factors influencing the ratio of p21 (CDKN1A) to PUMA (BBC3) expression.
  • Functional assessment of identified factors (TCF3/E2A, TRIAP1) on p53-mediated cellular responses.

Main Results:

  • The transcription factor TCF3 (E2A) was identified as a driver of p21 expression and a repressor of PUMA across various cancer cell types.
  • Depletion of TCF3/E2A impairs p53-induced cell-cycle arrest and enhances apoptosis.
  • TRIAP1 was identified as a specific repressor of p21, and its depletion slows cell-cycle progression.

Conclusions:

  • TCF3/E2A and TRIAP1 are critical regulators that balance p53-mediated cell-cycle arrest and apoptosis.
  • The study reveals specific molecular strategies to steer p53-activated cells towards desired outcomes.
  • These findings have implications for designing therapies that selectively induce cell-cycle arrest or apoptosis in cancer cells.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...